» Articles » PMID: 15836963

Where Do Triptans Act in the Treatment of Migraine?

Overview
Journal Pain
Specialties Neurology
Psychiatry
Date 2005 Apr 20
PMID 15836963
Citations 46
Authors
Affiliations
Soon will be listed here.
Citing Articles

Current and Novel Therapies for Cluster Headache: A Narrative Review.

de Freitas Dias B, Robinson C, Villar-Martinez M, Ashina S, Goadsby P Pain Ther. 2024; 14(1):1-19.

PMID: 39489854 PMC: 11751248. DOI: 10.1007/s40122-024-00674-7.


Regional distribution of unbound eletriptan and sumatriptan in the CNS and PNS in rats: implications for a potential central action.

Svane N, Ballgren F, Ginosyan A, Kristensen M, Brodin B, Loryan I J Headache Pain. 2024; 25(1):187.

PMID: 39478486 PMC: 11523665. DOI: 10.1186/s10194-024-01894-0.


Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms.

Kogelman L, Falkenberg K, Ottosson F, Ernst M, Russo F, Stentoft-Hansen V Sci Rep. 2023; 13(1):12395.

PMID: 37524744 PMC: 10390468. DOI: 10.1038/s41598-023-38904-1.


Medication overuse headache and substance use disorder: A comparison based on basic research and neuroimaging.

Li C, Dai W, Miao S, Xie W, Yu S Front Neurol. 2023; 14:1118929.

PMID: 36937526 PMC: 10017752. DOI: 10.3389/fneur.2023.1118929.


Revisiting Migraine: The Evolving Pathophysiology and the Expanding Management Armamentarium.

Gawde P, Shah H, Patel H, Bharathi K, Patel N, Sethi Y Cureus. 2023; 15(2):e34553.

PMID: 36879707 PMC: 9985459. DOI: 10.7759/cureus.34553.


References
1.
Harrison S, Balawi S, Feinmann C, Harris M . Atypical facial pain: a double-blind placebo-controlled crossover pilot study of subcutaneous sumatriptan. Eur Neuropsychopharmacol. 1997; 7(2):83-8. DOI: 10.1016/s0924-977x(96)00385-9. View

2.
Cumberbatch M, Hill R, Hargreaves R . Rizatriptan has central antinociceptive effects against durally evoked responses. Eur J Pharmacol. 1997; 328(1):37-40. DOI: 10.1016/s0014-2999(97)83024-5. View

3.
Limmroth V, May A, Auerbach P, Wosnitza G, Eppe T, Diener H . Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine. J Neurol Sci. 1996; 138(1-2):60-5. DOI: 10.1016/0022-510x(95)00344-2. View

4.
Dao T, Lund J, Remillard G, Lavigne G . Is myofascial pain of the temporal muscles relieved by oral sumatriptan? A cross-over pilot study. Pain. 1995; 62(2):241-244. DOI: 10.1016/0304-3959(95)00025-N. View

5.
Shepheard S, Williamson D, Williams J, Hill R, Hargreaves R . Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in Dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology. 1995; 34(3):255-61. DOI: 10.1016/0028-3908(94)00153-j. View